STUDY TO OBSERVE EFFECTS OF VARIOUS NEWLY AVAILABLE MANAGEMENT MODALITIES LIKE PHAKIC IOL(A TYPE OF INTRA-OCULAR LENS IMPLANTED IN EYE) , OCCLUTAB(A TYPE OF CONTRAST BASED APP IN A DIGITAL TABLET) WITH THE CONVENTIONAL EYE - PATCHING FOR PATIENTS OF A TYPE OF VISUAL IMPAIRMENT KNOWN AS AMBLYOPIA
Phase 4
- Conditions
- Health Condition 1: H530- Amblyopia ex anopsia
- Registration Number
- CTRI/2021/01/030394
- Lead Sponsor
- Dr Arvind Kumar Morya
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
To evaluate the efficacy of three treatment modalities - Occlutab , Phakic IOL and conventional ocular - patching in the patients of high myopic anisometropia and isometropia between the age of 10-23 years of both sexes.
Exclusion Criteria
1. Amblyopic patients of less than 10 and more than 23 years of age.
2. Amblyopic patients with hypermetropia.
3. Any history of ocular trauma, glaucoma.
4. Patients having Endothelial chamber depth of less than 2.8 mm.
5. Unstable refractive error.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method